Cargando…
Warburg effect enhanced by AKR1B10 promotes acquired resistance to pemetrexed in lung cancer-derived brain metastasis
BACKGROUND: Resistance to pemetrexed (PEM), a rare chemotherapeutic agent that can efficiently cross the blood-brain barrier, limits the therapeutic efficacy for patients with lung cancer brain metastasis (BM). Aldo-keto reductase family 1 B10 (AKR1B10) was recently found to be elevated in lung canc...
Autores principales: | Duan, Wenzhe, Liu, Wenwen, Xia, Shengkai, Zhou, Yang, Tang, Mengyi, Xu, Mingxin, Lin, Manqing, Li, Xinyu, Wang, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428599/ https://www.ncbi.nlm.nih.gov/pubmed/37587486 http://dx.doi.org/10.1186/s12967-023-04403-0 |
Ejemplares similares
-
Targeting of endothelial cells in brain tumours
por: Duan, Wenzhe, et al.
Publicado: (2023) -
Proteomic Reveals Reasons for Acquired Drug Resistance in Lung Cancer Derived Brain Metastasis Based on a Newly Established Multi-Organ Microfluidic Chip Model
por: Xu, Mingxin, et al.
Publicado: (2020) -
Glutathione peroxidase 4‐dependent glutathione high‐consumption drives acquired platinum chemoresistance in lung cancer‐derived brain metastasis
por: Liu, Wenwen, et al.
Publicado: (2021) -
AKR1B10 in gastrointestinal diseases
por: Shen, Yi, et al.
Publicado: (2015) -
GRP78 in lung cancer
por: Xia, Shengkai, et al.
Publicado: (2021)